NCT00650117View on ClinicalTrials.gov

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

Mylan Fentanyl Transdermal System 25 mcg/h + Scotch Duct Tape (3M)

single application

DRUG

Duragesic 25 mcg/h + Scotch Duct Tape (3M)

single application

DRUG

Mylan Fentanyl Transdermal System 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M)

single application

DRUG

Duragesic 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M)

single application

DRUG

Mylan Fentanyl Transdermal System 25 mcg/h + Microfoam Tape (3M)

single application

DRUG

Duragesic 25 mcg/h + Microfoam Tape (3M)

single application

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY